BioLife Solutions, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue27.5M18.8M28.1M25.4M23.9M-3.4M30.6M19.7M
Cost of Goods Sold10.1M6.1M10.8M9.0M8.2M11.7M8.8M6.5M
Gross Profit17.4M12.7M17.2M16.4M15.8M8.3M21.8M13.2M
R&D Expenses2.6M66K2.7M2.7M2.2M1.1M2.0M2.4M
Operating Expenses17.4M6.9M17.3M33.1M17.0M-16.5M23.4M14.5M
Operating Income27K5.8M-89K-16.6M-1.2M1.4M-1.6M-3.7M
Other Income / Gains1.2M-2.5M792K931K784K157K-172K-4.4M
Net Income1.2M3.5M621K-15.8M-448K12.5M-1.7M-20.7M
EPS (Diluted)0.0250.0770.013-0.33-0.010.27-0.037-0.45
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.6330.6750.6140.6460.659-2.4160.7130.67
General And Administrative Expenses12.2M10.5M12.1M11.4M11.5M6.6M11.4M9.3M
Selling And Marketing Expenses2.5M2.0M2.5M2.7M2.6M-791K3.5M2.5M
Selling General And Administrative Expenses14.7M12.5M14.6M14.1M14.1M5.8M14.9M11.8M
Other Expenses85K-5.8M699K16.2M702K-23.4M6.4M330K
Cost And Expenses27.5M13.0M28.2M42.1M25.2M-4.8M32.1M21.0M
Interest Income1.0M00684K681K000
Interest Expense0152K508K00-116K267K361K
Depreciation And Amortization699K1.4M1.3M1.4M1.4M1.7M2.3M2.4M
Ebitda726K4.9M1.2M-14.3M166K6.7M853K1.1M
Ebitdaratio0.0260.2610.044-0.5640.007-1.9710.0280.054
Operating Income Ratio0.0010.31-0.003-0.655-0.051-0.405-0.051-0.186
Income Before Tax1.2M3.4M703K-15.7M-434K1.5M-1.7M-8.1M
Income Before Tax Ratio0.0450.1790.025-0.618-0.018-0.451-0.057-0.409
Income Tax Expense62K-173K82K126K14K-131K-28K1K
Net Income Ratio0.0430.1880.022-0.623-0.019-3.639-0.056-1.051
Epsdiluted0.0240.0770.013-0.33-0.010.26-0.037-0.45
Weighted Average Shs Out48.5M47.8M47.9M47.8M47.1M46.6M46.2M46.0M
Weighted Average Shs Out Dil49.2M48.6M48.7M47.8M47.1M48.0M46.2M46.0M